190 related articles for article (PubMed ID: 16451076)
1. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action.
Vilar S; Santana L; Uriarte E
J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076
[TBL] [Abstract][Full Text] [Related]
2. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
3. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives.
Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y
J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516
[TBL] [Abstract][Full Text] [Related]
4. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
5. Prediction of anti-HIV-1 activity of a series of tetrapyrrole molecules.
Vanyúr R; Héberger K; Jakus J
J Chem Inf Comput Sci; 2003; 43(6):1829-36. PubMed ID: 14632429
[TBL] [Abstract][Full Text] [Related]
6. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
7. Prediction of biological targets using probabilistic neural networks and atom-type descriptors.
Niwa T
J Med Chem; 2004 May; 47(10):2645-50. PubMed ID: 15115405
[TBL] [Abstract][Full Text] [Related]
8. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.
Arab Chamjangali M; Beglari M; Bagherian G
J Mol Graph Model; 2007 Jul; 26(1):360-7. PubMed ID: 17350867
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
Chen KX; Xie HY; Li ZG; Gao JR
Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
Pinheiro JR; Bitencourt M; da Cunha EF; Ramalho TC; Freitas MP
Bioorg Med Chem; 2008 Feb; 16(4):1683-90. PubMed ID: 18053727
[TBL] [Abstract][Full Text] [Related]
12. Study of probabilistic neural networks to classify the active compounds in medicinal plants.
Xue CX; Zhang XY; Liu MC; Hu ZD; Fan BT
J Pharm Biomed Anal; 2005 Jul; 38(3):497-507. PubMed ID: 15925251
[TBL] [Abstract][Full Text] [Related]
13. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
[TBL] [Abstract][Full Text] [Related]
14. Modelling of cytotoxicity data (CC50) of anti-HIV 1-[5-chlorophenyl) sulfonyl]-1H-pyrrole derivatives using calculated molecular descriptors and Levenberg-Marquardt artificial neural network.
Arab Chamjangali M
Chem Biol Drug Des; 2009 Apr; 73(4):456-65. PubMed ID: 19291106
[TBL] [Abstract][Full Text] [Related]
15. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Mol Biosyst; 2012 Aug; 8(8):2188-96. PubMed ID: 22688327
[TBL] [Abstract][Full Text] [Related]
16. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S
Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
San Juan AA
Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
19. ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds.
González-Díaz H; Bonet I; Terán C; De Clercq E; Bello R; García MM; Santana L; Uriarte E
Eur J Med Chem; 2007 May; 42(5):580-5. PubMed ID: 17207560
[TBL] [Abstract][Full Text] [Related]
20. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
